Читать книгу Spectrums of Amyotrophic Lateral Sclerosis - Группа авторов - Страница 6

Contributors

Оглавление

Christen G. Chisholm, Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales, Australia

Roger S. Chung, Motor Neuron Disease Research Centre, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia

Robert A. Déziel, CNS Contract Research Corp, Charlottetown, Prince Edward Island, Canada

Patrick A. Dion, Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada

Angela Genge, Montreal Neurological Institute and Hospital, Montréal, Québec, Canada

Daphne A. Gill, CNS Contract Research Corp, Charlottetown, Prince Edward Island, Canada; Department of Biomedical Sciences, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada

Manuel Graeber, Brain Tumor Research Laboratories, Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia

Cheryl Y. Gregory‐Evans, Experimental Medicine Program, University of British Columbia, Vancouver, British Columbia, Canada; Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada

Denis G. Kay, Alpha Cognition Inc., Charlottetown, Prince Edward Island, Canada

Charles Krieger, Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, British Columbia, Canada; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Division of Neurology, Vancouver Coastal Health, Vancouver, British Columbia, Canada

Michael Kuo, Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada

Audrey Labarre, Department of Neuroscience, University of Montréal, Montréal, Québec, Canada; Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada

Serena Lattante, Unità Operativa Complessa di Genetica Medica, Dipartimento di Scienze di Laboratorio e Infettivologico, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Albert Lee, Motor Neuron Disease Research Centre, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia

Thomas E. Marler, College of Natural and Applied Sciences, University of Guam, Mangilao, Guam, USA

Amber L. Marriott, CNS Contract Research Corp, Charlottetown, Prince Edward Island, Canada

Luke McAlary, Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales, Australia

Jessica R. Morrice, Experimental Medicine Program, University of British Columbia, Vancouver, British Columbia, Canada

Marco Morsch, Motor Neuron Disease Research Centre, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia

Alex Parker, Department of Neuroscience, University of Montréal, Montréal, Québec, Canada; Centre de recherche du centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada

Rowan A.W. Radford, Motor Neuron Disease Research Centre, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia

Jay P. Ross, Department of Human Genetics, McGill University, Montréal, Québec, Canada; Montréal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada

Guy A. Rouleau, Department of Human Genetics, McGill University, Montréal, Québec, Canada; Montreal Neurological Institute and Hospital, McGill University, Montréal, Québec, Canada; Department of Neurology and Neurosurgery, McGill University, Montréal, Québec, Canada

Mario Sabatelli, Sezione di Medicina Genomica, Dipartimento Scienze della Vita e Sanità Pubblica, Facoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy

Kristiana Salmon, Montreal Neurological Institute and Hospital, Montréal, Québec, Canada

Natalie M. Scherer, Motor Neuron Disease Research Centre, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia

Christopher A. Shaw, Experimental Medicine Program, University of British Columbia, Vancouver, British Columbia, Canada; Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada; Program in Neuroscience, University of British Columbia, Vancouver, British Columbia, Canada

Ted Stehr, ALS Society of BC Director, and person living with ALS

Andres Vidal‐Itriago, Motor Neuron Disease Research Centre, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia

Justin J. Yerbury, Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia; Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales, Australia

Spectrums of Amyotrophic Lateral Sclerosis

Подняться наверх